Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion type Assertion NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_head.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion wasGeneratedBy ECO_0000203 NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_provenance.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion wasDerivedFrom befree-2016 NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_provenance.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion SIO_000772 19648968 NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_provenance.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion evidence source_evidence_literature NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_provenance.
- NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_assertion description "[ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754961.RACsW3MF5NZ-puMdEldHetIaqfmVE_XKoj6qzlx9F1Nhw130_provenance.